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Abstract
Objective: Primary osteosarcoma of the jaw bones is very rare, and histological fea-
tures of gnathic osteosarcoma remain obscure. The purpose of this study was to
describe the clinicopathological features of gnathic osteosarcoma.
Materials and methods: Seven cases of gnathic osteosarcoma from Japan diagnosed
during the period between 2000 and 2016 were examined retrospectively. The his-
tology of the surgical pathology materials was reviewed by two pathologists. Clinical
information was obtained from the hospital's information system.
Results: Of the seven cases, two patients had secondary osteosarcomas. As for the
five cases of primary osteosarcoma, their ages ranged from 26 to 58 years (mean:
36.2, median: 28). Histologically, three cases were fibrotic tumors composed of
spindle-shaped cells with mild to moderate nuclear atypia and the collagenous stroma
accompanied by woven bones or mature lamellar-like bones. Two cases had cartilage
formation. MDM2 and CDK4 expression was observed in two out of three cases on
immunostaining. The histopathology of these three cases was regarded as the coun-
terpart of low-grade osteosarcomas, namely, parosteal osteosarcoma and low-grade
central osteosarcoma, arising in long bones.
Conclusions: The surprisingly high incidence (60%, 3/5 cases) of low-grade osteosar-
coma explains the reason why gnathic osteosarcomas present a more favorable prog-
nosis than osteosarcomas arising in long bones. Furthermore, it provides insight into
the tumorigenesis mechanism of low-grade osteosarcomas arising in the jaw and
other sites.
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1 | INTRODUCTION
Primary osteosarcoma of the jaw bones accounts for approximately
10% of all osteosarcoma cases (Paparella et al., 2013; van den Berg
et al., 2013). Previous studies have proposed that gnathic
osteosarcomas occur in older ages compared to those affecting the
long bones, showing favorable prognoses (Lee et al., 2015; Paparella
et al., 2013). However, details regarding the histological feature of
gnathic osteosarcoma are still obscured. Some studies have indicated
that conventional osteosarcoma is the predominant histological type
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(Baumhoer et al., 2014; Bennett et al., 2000; Jasnau et al., 2008;
Thariat et al., 2013; van den Berg et al., 2013). Other studies have
shown a predominance of low-grade histology (Lopes et al., 2001;
Padilla & Murrah, 2011). Bennett et al. (2000) indicated that the
majority of tumors showed focal chondroid formation. To clarify
the specific clinicopathological features of gnathic osteosarcoma, we
reviewed seven Japanese cases.
Conventional osteosarcoma generally arises in teenagers, and
sites of predilection involve the metaphysis of the long bones, espe-
cially the distal femur and the proximal tibia. Microscopically, the neo-
plastic cells typically show severe atypia, producing varying amounts
of neoplastic bone. Conventional osteosarcoma is subdivided into
three histological patterns based on the neoplastic matrix compo-
nents, namely, osteoblastic, chondroblastic, and fibroblastic (Rozeman
et al., 2006; WHO Classification of Tumours Editorial Board, 2020).
Moreover, there are four specific types of osteosarcoma that show
peculiar histological and clinical features distinct from those of con-
ventional osteosarcoma. Among these specific types, parosteal osteo-
sarcoma and low-grade central osteosarcoma are its low-grade
variants. Parosteal osteosarcoma arises on the surface of the bone,
preferentially on the distal posterior femur followed by the proximal
portions of the tibia and humerus. Histologically, this variant demon-
strates spindle cell tumors with hypo- to moderate cellularity, forming
variable bone and cartilage components, wherein woven bone and
well-formed trabeculae are frequently observed. Its peak incidence
occurs in the third decade of life, with a slight female predominance.
Prognosis is usually excellent, but approximately 8%–25% of the
tumors show progression to the high-grade osteogenic or non-
osteogenic sarcoma, with a prognosis similar to that of conventional
osteosarcoma (Hang & Chen, 2014; Ruengwanichayakun et al., 2019).
On genetic analysis of this variant, chromosome amplification of the
region 12q13-15, which contains MDM2 and CDK4 genes was
observed in 85% of the cases (Yoshida et al., 2010). On the other
hand, low-grade central osteosarcoma has clinical and histological fea-
tures similar to those of parosteal osteosarcoma, except that it arises
within the medullary cavity of the bone (Schwab et al., 2008).
Parosteal osteosarcoma accounts for 4%, while low-grade central
osteosarcoma accounts for 1%–3% of all osteosarcomas, respectively
(Hang & Chen, 2014; Schwab et al., 2008).
In this study, we found that three out of a total of five cases who
had gnathic primary osteosarcoma showed clinicopathological fea-
tures such as low-grade osteosarcomas. Investigating these cases may
explain why gnathic osteosarcomas show a favorable prognosis as
compared to long bone osteosarcomas.
2 | MATERIALS AND METHODS
Diagnosed cases of jaw osteosarcoma, not otherwise specified of the
jaw at Keio University Hospital from 2000 to 2016, were obtained
from the laboratory information system. Both primary and secondary
osteosarcomas were included, while metastasis from other sites
(i.e., long bones) was excluded. Seven cases were obtained and
reviewed by two pathologists listed among the authors (AS and KK).
Clinical information was obtained from the hospital's information sys-
tem, and histological assessment was performed on the following
points: cellular atypia, osteoid formation, woven bone formation, car-
tilage formation, collagenous stroma formation, number of mitotic fig-
ures, and necrosis. Additionally, immunohistochemical studies were
performed on sections obtained from formalin-fixed, paraffin-
embedded tissues preserved at the Division of Diagnostic Pathology
Laboratory using BOND III Automated Immunostainer (BOND III,
Leica Biosystems, Wetzlar, Germany). The primary antibodies used in
the study were CDK4 (clone DCS-31, dilution 1: 200, Invitrogen,
Carlsbad, CA, USA) and MDM2 (clone IF2, dilution 1:200, Thermo
Fisher Scientific, Waltham, MA, USA), and a positive test was con-
firmed when approximately 30% of tumor cells showed significant
nuclear staining compared to the internal negative control cells.
The study protocol was approved by the Keio University School
of Medicine Ethics Committee (No. 20180087) and the Tokyo Dental
College Ichikawa General Hospital Ethics Committee (No. I19-01).
3 | RESULTS
The clinical features of seven cases are summarized in Table 1. The
study population comprised of one male and six females, of which
two patients had secondary osteosarcomas—cases 5 and 6. Notably,
TABLE 1 Summary of clinical
features
Case Age Sex Site Tx PH Met Outcome
1 26 F L/UJ Res None None ANED (10y)
2 27 F L/LJ CTx/Res None None ANED (18y)
3 28 F L/LJ Res None None N/A (3y)
4 42 F L/UJ CTx/Res None None ANED (5y)
5 55 M MS N/A RTx N/A N/A (1y)
6 57 F R/UJ HPTx FD None D (4y)
7 58 F R/LJ CTx/Res None Lung N/A (3y)
Abbreviations: ANED, alive no evidence of disease; CTx, chemotherapy; D, dead; F, female; FD, fibrous
dysplasia; HPTx, heavy particle therapy; L, left; LJ, lower jaw; M, male; Met, metastasis; MS, maxillary
sinus; N/A, not available; PH, past history; R, right; Res, resection; RTx, radiation therapy; Tx, treatment;
UJ, upper jaw.
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case 5 had a history of radiation therapy for squamous cell carcinoma
of the paranasal sinus 10 years prior to diagnosis of osteosarcoma,
but we had no further information regarding the hereditary predispo-
sition or genetic changes in this case. Case 6 was diagnosed with
fibrous dysplasia of the maxilla from approximately 20 years prior, but
GNAS mutation was not detected on cancer multi-gene panel testing.
The patients' ages ranged from 26 to 58 years (mean 41.9, median
42). As for five primary osteosarcoma cases, the age ranged from
26 to 58 years (mean: 36.2, median: 28). The maxilla and mandible
were almost equally affected in these cases.
Radiographic images were obtained from three cases: cases 1, 4,
and 6 (Figure S1). Computed tomography (CT) of case 1 prior to sec-
ond time resection showed a mineralized tumor around the left upper
jaw (Figure S1(a,b)). The patient had received initial resection of the
tumor 6 years before the second resection, and the initial pathological
diagnosis was a fibro-osseous lesion. However, images obtained
before the first resection were not available. Meanwhile, CT of case
4 showed a diffuse mass arising from the maxillary alveolar bone sur-
face invading the pterygopalatine fossa (Figure S1(c,d)), and CT of
case 6 showed a mineralized mass on the maxilla extending to the
nasal cavity (Figure S1(e,f )).
Histological evaluation was performed on biopsy specimens since
the histology had been modified on resected specimens by preopera-
tive chemotherapy. Microscopically, two secondary cases presented
with high-grade osteosarcoma with marked nuclear atypia and lace-
like osteoid formation, as typically observed in conventional osteo-
blastic osteosarcoma (Figure 1(a,b)). One out of five cases of primary
osteosarcoma presented with high-grade osteoblastic osteosarcoma
(case 3) (Figure 1(c)). Meanwhile, the remaining four primary cases
(cases 1, 2, 4, and 7) were fibrotic tumors composed of spindle-shaped
cells with mild to moderate nuclear atypia embedded in the collage-
nous stroma (Figure 2), and lace-like osteoids were rarely observed.
Moreover, woven bones or mature lamellar-like bones were observed
in cases 1 (Figure 2(b)), 2 (Figure 2(c,d)), and 4 (Figure 2(g)), and carti-
lages were observed in cases 2 and 4 (Figure 2(f)). The histological
diagnosis of osteosarcoma at biopsy was very challenging in case
7 due to the specimen's small size, wherein most of the sections
showed only moderate atypia (Figure 2(h)), and a small segment show-
ing severe atypia (Figure 4(b)) led to the diagnosis of osteosarcoma.
Additionally, mitotic figures were few in primary osteosarcomas,
namely, cases 1, 2, 3, and 4, meanwhile mitotic figures were rarely
observed in case 7; however, we could not quantify the number of
mitotic figures in case 7 because the specimen was too small. Notably,
tumor necrosis was observed only in case 5, the secondary osteosar-
coma following radiation therapy. Furthermore, MDM2 and CDK4
expression were observed on immunostaining in cases 1 (Figure 3(a,
b)), 4 (Figure 3(c,d)), and 7. The histological features of the biopsy
specimens are summarized in Tables 2 and 3.
Case 4 developed into a high-grade, non-osteogenic tumor (dedif-
ferentiation) 4 years after the first presentation to our hospital
(Figure 4(a)), and the details of this case have been described previ-
ously (Miyashita et al., 2018). Case 7 presented with lung metastasis
2 years after the first presentation, in which histology of the metasta-
sis was composed of a mixture of osteochondrogenic (Figure 4(c)) and
non-osteogenic (Figure 4(d)) tumors.
For treatment, two patients underwent simple resection (cases
1 and 3), and three underwent resection after chemotherapy (cases
2, 4, and 7). The therapeutic effects of chemotherapy showed a com-
plete response in case 7 and a partial response in cases 2 and
4, respectively. However, the outcomes of cases 3, 5, and 7 were not
F IGURE 1 High-grade conventional osteosarcomas showed in
case 5 (a), case 5 (b), and case 3 (c). The scale bars indicate 50 μm
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available because they were transferred to another hospital. Other
cases were alive, and the maximum observation period was 16 years.
The observation periods are shown in parenthesis in Table 1.
4 | DISCUSSION
In this study, five cases of primary osteosarcoma and two cases of
secondary osteosarcoma were assessed. The two cases of secondary
osteosarcoma (cases 5 and 6) occurred in the 50th decade of life and
presented with a high-grade osteosarcoma comparable to that of the
conventional osteosarcoma. The features were identical to those of
the secondary osteosarcoma that arises in the other bone sites. As for
cases of primary osteosarcoma, the mean age was 36 years, and there
was a female predominance. On the other hand, the histology was
quite different from that of conventional osteosarcoma in three cases
(cases 1, 2, and 4), presenting a fibrotic tumor with mild to moderate
cellular atypia. Furthermore, two out of these three (cases 1 and 4)
showed nuclear immunoreactivity to MDM2 and CDK4, indicating
their compatibility with low-grade osteosarcoma. Case 2 also seemed
F IGURE 2 Low- and intermediate-
grade osteosarcomas showed in case
1 (a,b), case 2 (c,d), and case 4 (e–g). Low-
grade osteosarcoma component of case
7 (h). The scale bars indicate 50 μm
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to morphologically has low-grade osteosarcoma features, although
MDM2 and CDK4 were not expressed immunohistochemically. The
absence of MDM2 and CDK4 expression could be ascribed to the fix-
ation and decalcification difficulties since case 2 was the oldest in this
study. Case 7 presented with a conventional high-grade osteosar-
coma, however, the presence of low-grade osteosarcoma components
(Figure 2(h)) and the MDM2 and CDK4 immunoreactivity suggests
that the patient had progressed from low-grade osteosarcoma. As
mentioned previously, low-grade osteosarcomas are divided into
parosteal osteosarcoma and low-grade central osteosarcoma based
on the sites of involvement. Case 1 macroscopically showed an extra-
and intramedullary mass macroscopically during the first re-
section (data not shown), and the case 4 presented a diffuse radi-
opaque lesion around the left molar region on CT imaging (Miyashita
et al., 2018), indicating that both cases had parosteal osteosarcoma. It
is difficult to determine between parosteal osteosarcoma and low-
grade central osteosarcoma in cases 2 and 7 due to the unavailability
of initial imaging or macroscopic pictures.
F IGURE 4 (a) Non-osteogenic high-
grade sarcoma observed in case
4. (b) High-grade osteosarcoma
component of case
7. (c) Osteochondrogenic tumor observed
in lung metastasis of case 7. (d) Non-
osteogenic tumor observed in lung
metastasis of case 7. The scale bars
indicate 50 μm
F IGURE 3 MDM2 and CDK4
immunostaining. (a) Case 1, MDM.
(b) Case 1, CDK4. (c) Case 4, MDM2.
(d) Case 4, CDK4. The scale bars
indicate 50 μm
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Chondroid differentiation has been identified in approximately
half of the cases of parosteal osteosarcoma (Hang & Chen, 2014;
WHO Classification of Tumours Editorial Board, 2020). In our
cases, two out of three low-grade osteosarcomas contain cartilage.
Although there is no significant difference in survival between the
histological subtypes of conventional osteosarcoma, it has been
suggested that chondroblastic tumors have a slightly better sur-
vival despite poor response to chemotherapy (Hauben
et al., 2002). These results indicate that chondroid differentiation
may be regarded as a well-differentiated phenotype of
osteosarcomas.
It is difficult to assess the prognosis of gnathic osteosarcomas in
our cases since the observation period was less than 5 years in most
cases. However, it is remarkable that case 1 had been alive for
10 years with no evidence of disease, even though she had not under-
gone chemotherapy.
As for long bones, low-grade osteosarcomas account for 5%–6%
of all osteosarcomas (Hang & Chen, 2014; Schwab et al., 2008). In our
cases, 60% (3 out of 5 cases) of gnathic primary osteosarcomas pres-
ented with low-grade osteosarcoma, which is a significantly high rate.
Although our study has limitations due to its small sample size and
short observation period, the results may infer why gnathic osteosar-
comas show a favorable prognosis as compared to osteosarcomas
arising in long bones.
In some previous reports, low-grade osteosarcomas were not pre-
dominant as compared to conventional osteosarcomas in gnathic
cases (Baumhoer et al., 2014; Bennett et al., 2000; Jasnau et al., 2008;
Thariat et al., 2013; van den Berg et al., 2013). This discrepancy with
our findings may be attributed to not only the difference in sample
size, but also racial differences since the above-cited reports were all
from European ethnicity. Another reason for this disparity could be
the limited observation period for each study. In the past, when low-
grade osteosarcomas were overlooked by clinicians and pathologists,
it could be misdiagnosed as a benign disease, such as fibrous dysplasia
(Tabatabaei et al., 2015). Therefore, a study that constitutes a large
number of old cases from the 1960s and the 1970s may show no pre-
dominance of low-grade osteosarcomas.
The rationale behind the high incidence of low-grade osteosarco-
mas in gnathic osteosarcomas is unclear. We speculate that the osteo-
genesis peculiar to jawbones may be related to the pathogenesis of
low-grade osteosarcomas. There are two known pathways of osteo-
genesis: endochondral ossification and intramembranous ossification
(Long & Ornitz, 2013; Su et al., 2018). In endochondral ossification,
the cartilaginous mold is first formed from the mesenchymal cells. The
mineralized cartilage is then replaced with bone matrix produced by
osteoblasts derived from the periosteum. This ossification process
occurs at the ossification center, situated in the metaphysis
(Tabatabaei et al., 2015). However, in intramembranous ossification,
however, mesenchymal cells directly differentiate into osteoblasts and
form the bone matrix without prior cartilage formation (Runyan &
Gabrick, 2017). Most of the bones, including the long bones of the
limbs, undergo endochondral ossification. In contrast, the craniofacial
bones, including the maxilla and mandible, mainly undergo intra-
membranous ossification during osteogenesis (Runyan &
Gabrick, 2017). Intramembranous ossification also occurs at the sur-
face of long bones or in the medullary cavity during the remodeling
phase (Frohlich et al., 2008). Although the etiology of osteosarcoma is
still unknown, several studies, using in vivo assays or mouse model
systems have suggested that growth factors and signaling cascades
working on the growth plate play roles in the development of osteo-
sarcoma (He et al., 2017; Rubio et al., 2014). This fact leads to the
speculation that the disturbance of the growth signals during endo-
chondral ossification may be an essential cause of conventional
TABLE 2 Summary of histological
features
Case Atypia Osteoid WB Cart CF Mitosis Necrosis
1 M ± +  ++ 3 per 50 HPF 
2 M ± + + + 0 per 50 HPF 
3 M to H + +   2 per 50 HPF 
4 L to M  + + ++ 1 per 50 HPF 
5 H + +  + 66 per 50 HPF +
6 H ++ ±  + 17 per 50 HPF 
7 M to H ± ±  ++ n.d. 
Note: The symbols indicate as the following: (++), markedly positive; (+), positive; (±), positive but very
minor component; (), negative.
Abbreviations: Cart, cartilage; CF, collagen fiber; H, high; HPF, high-power field; L, low; M, moderate;
WB, woven bone.







6 +, focal +, focal
7 + +
Note: The symbols indicate as the following: (+), positive throughout the
tumor; (±), positive but weak; (), negative. The words (+, focal) indicate
that the positive area is focal.
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osteosarcoma. As for jawbones, which mainly undergo intra-
membranous ossification, the different oncogenic signals may play a
role in the tumorigenesis of osteosarcoma. It is remarkable that both
parosteal osteosarcoma and low-grade central osteosarcoma of the
long bones both seem to arise at sites and in ages that usually do not
present with endochondral ossification. Therefore, it is speculated
that oncogenic signals of low-grade osteosarcomas arising both in the
jaws and long bones are closely related to the growing signals of intra-
membranous ossification, which is different from that of endochon-
dral ossification. For example, platelet-derived growth factors
(PDGFs) and PDGF receptors (PDGFRs), which promote the migration
of mesenchymal stem cells at intramembranous ossification sites, are
variably expressed in osteosarcomas (Shah et al., 2014; Xu
et al., 2018). Interestingly, PDFGR signaling promotes tumorigenesis
in concert with CDK4 in a murine glioma model (Hoeman et al., 2018).
It has been suggested that MDM2 and the PI3K/AKT/mTOR path-
way, which is one of the downstream PDGFR pathways, work syner-
gistically (Laroche et al., 2017). Therefore, the MDM2 and CDK4,
usually amplified in low-grade osteosarcomas, might be key molecules
involved in the tumorigenesis of low-grade osteosarcomas. The
tumorigenesis mechanism of osteosarcomas, both conventional and
low-grade, gnathic, and other sites must be elucidated in further
investigations.
5 | CONCLUSION
We found three out of five cases of gnathic primary osteosarcomas
which showed clinicopathological features resembling those of low-
grade osteosarcomas. The surprisingly high incidence (60%, 3/5 cases)
of low-grade osteosarcoma may explain the reason why gnathic oste-
osarcomas present a more favorable prognosis compared to osteosar-
comas arising in long bones. Furthermore, it postulates that the
tumorigenesis mechanism of low-grade osteosarcomas arising in
the jaw and the other sites might be closely related to intra-
membranous ossification.
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